Atara Biotherapeutics Income Statement 2012-2025 | ATRA

Revenue

$128.94

$8.573

$63.573

$20.34

Cost Of Goods Sold

$21.009

$8.886

Gross Profit

$107.931

$-0.313

$63.573

$20.34

Research And Development Expenses

$151.483

$224.785

$272.533

$282.001

$244.65

$216.097

$167.457

$81.206

$56.514

$41.618

SG&A Expenses

$39.886

$50.908

$71.553

$78.801

$64.402

$79.584

$69.654

$40.326

$24.728

$16.83

Other Operating Income Or Expenses

Operating Expenses

$191.369

$275.693

Operating Income

$-83.438

$-276.006

$-280.513

$-340.462

$-309.052

$-295.681

$-237.111

$-121.532

$-81.242

$-58.448

Total Non-Operating Income/Expense

$-1.977

$-0.105

$52.223

$0.367

$2.447

$4.717

$6.368

$2.027

$2.203

$1.218

Pre-Tax Income

$-85.415

$-276.111

$-228.29

$-340.095

$-306.605

$-290.964

$-230.743

$-119.505

$-79.039

$-57.23

Income Taxes

$-0.012

$0.015

$0.012

$0.046

$0.015

$0.012

$-0.044

$-0.014

$0.01

$-0.009

Income After Taxes

$-85.403

$-276.126

$-228.302

$-340.141

$-306.62

$-290.976

$-230.699

$-119.491

$-79.049

$-57.221

Other Income

Income From Continuous Operations

$-85.403

$-276.126

$-228.302

$-340.141

$-306.62

$-290.976

$-230.699

$-119.491

$-79.049

$-57.221

Income From Discontinued Operations

Net Income

$-85.403

$-276.126

$-228.302

$-340.141

$-306.62

$-290.976

$-230.699

$-119.491

$-79.049

$-57.221

EBITDA

$-78.627

$-270.385

$-273.836

$-329.348

$-299.892

$-289.941

$-235.264

$-119.844

$-78.277

$-54.935

EBIT

$-83.438

$-276.006

$-280.513

$-340.462

$-309.052

$-295.681

$-237.111

$-121.532

$-81.242

$-58.448

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-11.41

$-65.19

$-56.00

$-90.75

$-103.75

$-141.75

$-131.75

$-100.00

$-68.75

$-56.00

EPS - Earnings Per Share

$-11.41

$-65.19

$-56.00

$-90.75

$-103.75

$-141.75

$-131.75

$-100.00

$-68.75

$-56.00